{"id":"nutropin-aq","safety":{"commonSideEffects":[{"rate":null,"effect":"Injection site reactions"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Hypothyroidism"},{"rate":null,"effect":"Carpal tunnel syndrome"},{"rate":null,"effect":"Fluid retention"},{"rate":null,"effect":"Gynecomastia"}]},"_chembl":{"chemblId":"CHEMBL1945534","moleculeType":"Small molecule","molecularWeight":"5841.92"},"_dailymed":{"setId":"139d2038-e6a9-4ab1-ab00-aa7d8aa8df5f","title":"NUTROPIN AQ NUSPIN 5 (SOMATROPIN) INJECTION, SOLUTION NUTROPIN AQ NUSPIN 10 (SOMATROPIN) INJECTION, SOLUTION NUTROPIN AQ NUSPIN 20 (SOMATROPIN) INJECTION, SOLUTION [GENENTECH, INC.]"},"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Nutropin AQ (somatropin) is a synthetic form of human growth hormone produced via recombinant DNA technology. It activates growth hormone receptors on target tissues, promoting linear growth, protein synthesis, and lipolysis while reducing fat mass. It is used to treat growth hormone deficiency and other growth disorders in children and adults.","oneSentence":"Nutropin AQ is a recombinant human growth hormone that binds to growth hormone receptors to stimulate growth and metabolic processes.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:57:56.507Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Growth hormone deficiency in children"},{"name":"Growth hormone deficiency in adults"},{"name":"Short stature associated with Turner syndrome"},{"name":"Idiopathic short stature"}]},"trialDetails":[{"nctId":"NCT06558422","phase":"PHASE1","title":"Human Models of Selective Insulin Resistance: Pancreatic Clamp","status":"NOT_YET_RECRUITING","sponsor":"Columbia University","startDate":"2027-01-01","conditions":"Insulin Resistance, Hyperinsulinemia, Metabolic Dysfunction Associated Steatotic Liver Disease","enrollment":36},{"nctId":"NCT05724134","phase":"PHASE1","title":"Pancreatic Clamp in NAFLD","status":"COMPLETED","sponsor":"Columbia University","startDate":"2023-08-29","conditions":"Insulin Resistance, Prediabetic State, Hyperinsulinemia","enrollment":18},{"nctId":"NCT00803179","phase":"PHASE1","title":"Growth Hormone Therapy for Wasting in Cystic Fibrosis","status":"TERMINATED","sponsor":"University of Massachusetts, Worcester","startDate":"2008-11","conditions":"Cystic Fibrosis","enrollment":5},{"nctId":"NCT06126354","phase":"PHASE1","title":"Dexamethasone/Pancreatic Clamp P&F","status":"WITHDRAWN","sponsor":"Columbia University","startDate":"2024-07-01","conditions":"Insulin Resistance, Prediabetic State, Non-Alcoholic Fatty Liver Disease","enrollment":""},{"nctId":"NCT06103513","phase":"PHASE3","title":"Randomized Clinical Trial of Two Different Initial Growth Hormone Doses in Children","status":"UNKNOWN","sponsor":"Northwell Health","startDate":"2023-12-10","conditions":"Growth Disorders, Growth Failure, Growth Hormone Treatment","enrollment":50},{"nctId":"NCT03123913","phase":"PHASE1","title":"Study of Testosterone and rHGH in FSHD","status":"COMPLETED","sponsor":"University of Rochester","startDate":"2017-12-18","conditions":"Facioscapulohumeral Muscular Dystrophy","enrollment":20},{"nctId":"NCT00444964","phase":"PHASE3","title":"Growth Hormone Use in Adults With Prader-Willi Syndrome","status":"COMPLETED","sponsor":"Children's Mercy Hospital Kansas City","startDate":"2005-04","conditions":"Prader-Willi Syndrome","enrollment":11},{"nctId":"NCT00109473","phase":"PHASE2","title":"Trial of Growth Hormone Therapy in Pediatric Crohn's Disease","status":"COMPLETED","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2005-04","conditions":"Crohn's Disease","enrollment":22},{"nctId":"NCT00283595","phase":"PHASE2","title":"Effect of Growth Hormone on Bone Metabolism in Anorexia Nervosa","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2006-01","conditions":"Anorexia Nervosa, Osteopenia, Osteoporosis","enrollment":21},{"nctId":"NCT02179255","phase":"PHASE1, PHASE2","title":"Human Growth Hormone Pre-treatment for 6 Weeks Prior to Ovulation Induction for IVF","status":"UNKNOWN","sponsor":"Center for Human Reproduction","startDate":"2014-08-01","conditions":"Female Infertility Due to Diminished Ovarian Reserve","enrollment":30},{"nctId":"NCT01438801","phase":"PHASE4","title":"Predictive Value of the Insulin-like Growth Factor-1 (IGF-1) Generation Test for the Growth Response to Growth Hormone Treatment (PRED-IGF)","status":"WITHDRAWN","sponsor":"Ipsen","startDate":"2013-05","conditions":"Idiopathic Short Stature","enrollment":""},{"nctId":"NCT00256555","phase":"PHASE2, PHASE3","title":"Growth Hormone Treatment Study in Children With Cystic Fibrosis","status":"WITHDRAWN","sponsor":"University of Texas Southwestern Medical Center","startDate":"2000-02","conditions":"Cystic Fibrosis","enrollment":""},{"nctId":"NCT02311894","phase":"PHASE4","title":"A Post-Marketing Study of the Immunogenicity of Somatropin (Ribosomal Deoxyribo Nucleic Acid [rDNA] Origin) Injection (Nutropin AQ®) in Children With Growth Hormone Deficiency","status":"COMPLETED","sponsor":"Genentech, Inc.","startDate":"2015-03-31","conditions":"Growth Hormone Deficiency","enrollment":82},{"nctId":"NCT00286676","phase":"PHASE2, PHASE3","title":"The Use of Nutropin Depot in HIV-infected Adult Males","status":"WITHDRAWN","sponsor":"University of Texas Southwestern Medical Center","startDate":"2006-02-01","conditions":"HIV Infection","enrollment":""},{"nctId":"NCT00748969","phase":"PHASE2, PHASE3","title":"Clinical Trial of Growth Hormone in MPS I, II, and VI","status":"TERMINATED","sponsor":"Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center","startDate":"2008-11","conditions":"Mucopolysaccharidosis I, Mucopolysaccharidosis II, Mucopolysaccharidosis VI","enrollment":2},{"nctId":"NCT01970800","phase":"NA","title":"The Role of Igf-1 Generation Test in Diagnosis and Treatment of Short Stature","status":"WITHDRAWN","sponsor":"Maimonides Medical Center","startDate":"2013-01","conditions":"Short Stature","enrollment":""},{"nctId":"NCT01248416","phase":"PHASE3","title":"Aromatase Inhibitors, Alone And In Combination With Growth Hormone In Adolescent Boys With Idiopathic Short Stature","status":"COMPLETED","sponsor":"Nemours Children's Clinic","startDate":"2010-11","conditions":"Idiopathic Short Stature","enrollment":76},{"nctId":"NCT03554031","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of Recombinant Human Growth Hormone Injection in Patients With Prader-Willi Syndrome","status":"UNKNOWN","sponsor":"Changchun GeneScience Pharmaceutical Co., Ltd.","startDate":"2018-04-14","conditions":"Prader-Willi Syndrome","enrollment":30},{"nctId":"NCT03221933","phase":"PHASE2","title":"A Study of Recombinant Human Growth Hormone Injection（JINTOPIN AQ）for Short Children With Small for SGA","status":"COMPLETED","sponsor":"Changchun GeneScience Pharmaceutical Co., Ltd.","startDate":"2009-12","conditions":"Small for Gestational Age Infant","enrollment":120},{"nctId":"NCT03245333","phase":"PHASE3","title":"A Study of Recombinant Human Growth Hormone Injection for Short Children With Small for Small for Gestational Age(SGA)","status":"UNKNOWN","sponsor":"Changchun GeneScience Pharmaceutical Co., Ltd.","startDate":"2014-12","conditions":"Small for Gestational Age Infant","enrollment":120},{"nctId":"NCT01007071","phase":"PHASE3","title":"Effects of Growth Hormone on Cognition and Cerebral Metabolism in Adults With Growth Hormone Deficiency","status":"COMPLETED","sponsor":"Stanford University","startDate":"2009-11-01","conditions":"Hypopituitarism","enrollment":11},{"nctId":"NCT01342146","phase":"PHASE2","title":"Efficiency and Safety Study of Pegylated Somatropin to Treat Growth Hormone Deficiency Children","status":"COMPLETED","sponsor":"Changchun GeneScience Pharmaceutical Co., Ltd.","startDate":"2006-05","conditions":"Growth Hormone Deficiency","enrollment":101},{"nctId":"NCT01495468","phase":"PHASE3","title":"Phase III Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat Growth Hormone Deficiency Children","status":"COMPLETED","sponsor":"Changchun GeneScience Pharmaceutical Co., Ltd.","startDate":"2007-03","conditions":"Growth Hormone Deficiency","enrollment":343},{"nctId":"NCT02976675","phase":"PHASE4","title":"Pegylated Somatropin (PEG Somatropin) in the Treatment of Children With Growth Hormone Deficiency","status":"UNKNOWN","sponsor":"Changchun GeneScience Pharmaceutical Co., Ltd.","startDate":"2015-01","conditions":"Growth Hormone Deficiency","enrollment":600},{"nctId":"NCT00616278","phase":"","title":"National Cooperative Growth Study in CKD","status":"COMPLETED","sponsor":"University of California, Davis","startDate":"2005-10","conditions":"Growth Hormone Deficiency","enrollment":27},{"nctId":"NCT00362063","phase":"NA","title":"304-C03/L3301n: Effects of Growth Hormone on Glucose and Protein Metabolism in Children With Growth Hormone Deficiency","status":"UNKNOWN","sponsor":"Baylor College of Medicine","startDate":"2006-01","conditions":"Growth Hormone Deficiency","enrollment":20},{"nctId":"NCT00097539","phase":"","title":"National Cooperative Growth Study (NCGS): A Post-marketing Surveillance Program for Nutropin, Nutropin AQ, Nutropin Depot, and Protropin","status":"COMPLETED","sponsor":"Genentech, Inc.","startDate":"1985-10","conditions":"Growth Disorders","enrollment":65205},{"nctId":"NCT01243892","phase":"","title":"A Study to Evaluate Growth in Participants Treated With Somatropin (Nutropin) Using NuSpin Device","status":"TERMINATED","sponsor":"Genentech, Inc.","startDate":"2010-11","conditions":"Growth Hormone Deficiency","enrollment":18},{"nctId":"NCT02801565","phase":"NA","title":"Clinical Observation of Recombinant Human Growth Hormone Injection Assisted IVF-ET in the Treatment of PCOS","status":"UNKNOWN","sponsor":"Changchun GeneScience Pharmaceutical Co., Ltd.","startDate":"2016-02","conditions":"Polycystic Ovary Syndrome","enrollment":208},{"nctId":"NCT00134420","phase":"PHASE3","title":"Growth Hormone and Chromosome 18q- and Abnormal Growth","status":"COMPLETED","sponsor":"The University of Texas Health Science Center at San Antonio","startDate":"2001-02","conditions":"Loss of Chromosome 18q, Growth Hormone Deficiency","enrollment":20},{"nctId":"NCT02801591","phase":"","title":"Effect of Recombinant Human Growth Hormone Injection on the Clinical Outcome of POR in Patients Undergoing IVF/ET","status":"UNKNOWN","sponsor":"Changchun GeneScience Pharmaceutical Co., Ltd.","startDate":"2016-02","conditions":"Poor Ovarian Response","enrollment":240},{"nctId":"NCT00131378","phase":"NA","title":"Growth Hormone, Cardiovascular Risk, and Visceral Adiposity","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2004-11","conditions":"Obesity","enrollment":142},{"nctId":"NCT00943995","phase":"PHASE3","title":"Three Times Weekly (TIW) Growth Hormone Therapy in Children on Hemodialysis","status":"COMPLETED","sponsor":"Nationwide Children's Hospital","startDate":"2010-07","conditions":"Kidney Failure, Chronic, Renal Dialysis","enrollment":3},{"nctId":"NCT00140413","phase":"PHASE4","title":"Endocrine Dysfunction and Growth Hormone Deficiency in Children With Optic Nerve Hypoplasia","status":"COMPLETED","sponsor":"Children's Hospital Los Angeles","startDate":"2004-12","conditions":"Growth Hormone Deficiency, Septo-Optic Dysplasia, Hypopituitarism","enrollment":20},{"nctId":"NCT01512095","phase":"PHASE1","title":"Bioequivalence of Two Products (Norditropin® Versus Nutropin AQ®) in Healthy Adult Volunteers","status":"WITHDRAWN","sponsor":"Novo Nordisk A/S","startDate":"2013-08","conditions":"Growth Disorder, Healthy","enrollment":""},{"nctId":"NCT00518635","phase":"NA","title":"Low Dose Growth Hormone in Obese PCOS Women","status":"WITHDRAWN","sponsor":"Oregon Health and Science University","startDate":"2010-10","conditions":"Polycystic Ovary Syndrome","enrollment":""},{"nctId":"NCT00097526","phase":"","title":"Bone Mineral Density (BMD) in Adolescents With Growth Hormone Deficiency (GHD)","status":"COMPLETED","sponsor":"Genentech, Inc.","startDate":"2000-04","conditions":"Dwarfism, Pituitary, Turner Syndrome","enrollment":125},{"nctId":"NCT00097617","phase":"","title":"A Study in Children With Growth Failure Due to Chronic Renal Insufficiency (CRI) or End Stage Renal Disease (ESRD)","status":"COMPLETED","sponsor":"Genentech, Inc.","startDate":"2002-03","conditions":"Chronic Renal Insufficiency, End-Stage Renal Disease","enrollment":395},{"nctId":"NCT01613573","phase":"PHASE1","title":"Crossover Study to Assess the Safety and Pharmacokinetic of Pegylated Somatropin(PEG Somatropin) in GHD Children","status":"COMPLETED","sponsor":"Changchun GeneScience Pharmaceutical Co., Ltd.","startDate":"2010-03","conditions":"Growth Hormone Deficiency","enrollment":12},{"nctId":"NCT00212758","phase":"PHASE4","title":"A Study to Optimize Growth Hormone Dosing in Children With Chronic Kidney Disease by Measuring IGF-1 Levels in Blood","status":"COMPLETED","sponsor":"Oregon Health and Science University","startDate":"2005-01","conditions":"Kidney Failure, Chronic, Growth Hormone Deficiency","enrollment":17},{"nctId":"NCT00133354","phase":"PHASE2, PHASE3","title":"Arimidex Multicenter Trial in Growth Hormone (GH) Deficient Boys","status":"COMPLETED","sponsor":"Nemours Children's Clinic","startDate":"2001-11","conditions":"Hypopituitarism","enrollment":53},{"nctId":"NCT00097513","phase":"","title":"National Cooperative Growth Study (NCGS) of Optimal Nutropin AQ and Nutropin Dosing in Pubertal Growth Hormone-Deficient (GHD) Patients","status":"COMPLETED","sponsor":"Genentech, Inc.","startDate":"2003-02","conditions":"Dwarfism, Pituitary","enrollment":""},{"nctId":"NCT00149708","phase":"NA","title":"Consequence of Lifetime Isolated Growth Hormone Deficiency","status":"COMPLETED","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"2005-09","conditions":"Growth Hormone Deficiency","enrollment":400},{"nctId":"NCT00121875","phase":"","title":"Study to Identify Markers of Insulin Resistance During Growth Hormone Treatment for Short Stature","status":"TERMINATED","sponsor":"Massachusetts General Hospital","startDate":"2005-06","conditions":"Turner Syndrome, Idiopathic Short Stature","enrollment":1},{"nctId":"NCT00837863","phase":"PHASE2","title":"Study of Weekly ALTU-238 Compared With Daily Nutropin AQ in Prepubertal Children With Growth Hormone Deficiency","status":"UNKNOWN","sponsor":"Altus Pharmaceuticals","startDate":"2009-03","conditions":"Growth Hormone Deficiency","enrollment":36},{"nctId":"NCT00079742","phase":"PHASE2","title":"A Study to Evaluate Nutropin AQ for the Treatment of Growth Restriction in Children With Cystic Fibrosis","status":"COMPLETED","sponsor":"Genentech, Inc.","startDate":"2003-09","conditions":"Cystic Fibrosis","enrollment":68}],"_emaApprovals":[],"_faersSignals":[{"count":768,"reaction":"NO ADVERSE EVENT"},{"count":439,"reaction":"HEADACHE"},{"count":419,"reaction":"INJECTION SITE PAIN"},{"count":265,"reaction":"OFF LABEL USE"},{"count":256,"reaction":"FATIGUE"},{"count":236,"reaction":"ARTHRALGIA"},{"count":229,"reaction":"PAIN"},{"count":202,"reaction":"PRODUCT STORAGE ERROR"},{"count":186,"reaction":"PRODUCT DOSE OMISSION ISSUE"},{"count":181,"reaction":"DRUG DOSE OMISSION"}],"_approvalHistory":[{"date":"19970324","type":"SUPPL","sponsor":"GENENTECH","applicationNumber":"BLA020522"},{"date":"20080103","type":"SUPPL","sponsor":"GENENTECH","applicationNumber":"BLA020522"},{"date":"20140618","type":"SUPPL","sponsor":"GENENTECH","applicationNumber":"BLA020522"},{"date":"20051118","type":"SUPPL","sponsor":"GENENTECH","applicationNumber":"BLA020522"},{"date":"20070215","type":"SUPPL","sponsor":"GENENTECH","applicationNumber":"BLA020522"},{"date":"20020422","type":"SUPPL","sponsor":"GENENTECH","applicationNumber":"BLA020522"},{"date":"20010502","type":"SUPPL","sponsor":"GENENTECH","applicationNumber":"BLA020522"},{"date":"20250709","type":"SUPPL","sponsor":"GENENTECH","applicationNumber":"BLA020522"},{"date":"20050628","type":"SUPPL","sponsor":"GENENTECH","applicationNumber":"BLA020522"},{"date":"20000413","type":"SUPPL","sponsor":"GENENTECH","applicationNumber":"BLA020522"},{"date":"20160317","type":"SUPPL","sponsor":"GENENTECH","applicationNumber":"BLA020522"},{"date":"19991201","type":"SUPPL","sponsor":"GENENTECH","applicationNumber":"BLA020522"},{"date":"19991124","type":"SUPPL","sponsor":"GENENTECH","applicationNumber":"BLA020522"},{"date":"20160113","type":"SUPPL","sponsor":"GENENTECH","applicationNumber":"BLA020522"},{"date":"19980925","type":"SUPPL","sponsor":"GENENTECH","applicationNumber":"BLA020522"},{"date":"19980709","type":"SUPPL","sponsor":"GENENTECH","applicationNumber":"BLA020522"},{"date":"20150526","type":"SUPPL","sponsor":"GENENTECH","applicationNumber":"BLA020522"},{"date":"20161130","type":"SUPPL","sponsor":"GENENTECH","applicationNumber":"BLA020522"},{"date":"19970912","type":"SUPPL","sponsor":"GENENTECH","applicationNumber":"BLA020522"},{"date":"20140515","type":"SUPPL","sponsor":"GENENTECH","applicationNumber":"BLA020522"},{"date":"19960807","type":"SUPPL","sponsor":"GENENTECH","applicationNumber":"BLA020522"},{"date":"20080103","type":"SUPPL","sponsor":"GENENTECH","applicationNumber":"BLA020522"},{"date":"20130917","type":"SUPPL","sponsor":"GENENTECH","applicationNumber":"BLA020522"},{"date":"19951229","type":"ORIG","sponsor":"GENENTECH","applicationNumber":"BLA020522"},{"date":"20080103","type":"SUPPL","sponsor":"GENENTECH","applicationNumber":"BLA020522"},{"date":"20010917","type":"SUPPL","sponsor":"GENENTECH","applicationNumber":"BLA020522"},{"date":"20050628","type":"SUPPL","sponsor":"GENENTECH","applicationNumber":"BLA020522"},{"date":"20010917","type":"SUPPL","sponsor":"GENENTECH","applicationNumber":"BLA020522"},{"date":"20160518","type":"SUPPL","sponsor":"GENENTECH","applicationNumber":"BLA020522"},{"date":"19991013","type":"SUPPL","sponsor":"GENENTECH","applicationNumber":"BLA020522"},{"date":"20160226","type":"SUPPL","sponsor":"GENENTECH","applicationNumber":"BLA020522"},{"date":"19980925","type":"SUPPL","sponsor":"GENENTECH","applicationNumber":"BLA020522"},{"date":"19991103","type":"SUPPL","sponsor":"GENENTECH","applicationNumber":"BLA020522"},{"date":"20130718","type":"SUPPL","sponsor":"GENENTECH","applicationNumber":"BLA020522"},{"date":"20150623","type":"SUPPL","sponsor":"GENENTECH","applicationNumber":"BLA020522"},{"date":"19981026","type":"SUPPL","sponsor":"GENENTECH","applicationNumber":"BLA020522"},{"date":"20161213","type":"SUPPL","sponsor":"GENENTECH","applicationNumber":"BLA020522"},{"date":"19971217","type":"SUPPL","sponsor":"GENENTECH","applicationNumber":"BLA020522"},{"date":"20120410","type":"SUPPL","sponsor":"GENENTECH","applicationNumber":"BLA020522"}],"publicationCount":3,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Growth Hormone","Growth Hormone (Nutropin AQ)","Growth Hormone (GH)","Growth hormone"],"phase":"marketed","status":"active","brandName":"Nutropin AQ","genericName":"Nutropin AQ","companyName":"Children's Mercy Hospital Kansas City","companyId":"children-s-mercy-hospital-kansas-city","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Nutropin AQ is a recombinant human growth hormone (rhGH) injection used to treat conditions such as Growth Hormone Deficiency, Prader-Willi Syndrome, Idiopathic Short Stature, Poor Ovarian Response, and Turner Syndrome. It stimulates growth, cell reproduction, and cell regeneration by increasing the production of insulin-like growth factor 1 (IGF-1) and affecting glucose and free fatty acid levels.","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"supplemented","approval_date":"1995-12-29T00:00:00.000Z","mah":"GENENTECH","brand_name_local":null,"application_number":"BLA020522"}],"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}